STereotactic Ablative RadioTherapy in NEWly diagnosed and recurrent locally advanced non-small cell lung cancer patients unfit for concurrEnt RAdio-chemotherapy: early analysis of the START-NEW-ERA non-randomised phase II trial.
International journal of radiation oncology, biology, physics（2022）
摘要
LA-NSCLC patients treated with SAbR had optimal LC and promising OS in absence of ≥G3 toxicity. Our early outcomes would suggest the feasibility of using this approach in LA-NSCLC patients unfit for concurrent ChT-RT.
更多查看译文
关键词
Chemo-radiotherapy,Durvalumab,Local control,Stereotactic ablative radiotherapy,Unresectable locally-advanced non-small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要